Summary & Overview
CPT 49215: Excision of Sacrococcygeal Mass
CPT code 49215 represents surgical excision of an abnormal mass in the sacrococcygeal region near the base of the spine, a procedure most often relevant for newborns with sacrococcygeal tumors. This code captures a relatively specialized pediatric surgical service used for both diagnostic and therapeutic management of benign and malignant lesions in the coccygeal area. Nationally, accurate coding for 49215 matters for clinical documentation, resource planning, and appropriate payment for perioperative and inpatient services associated with complex neonatal or pediatric surgery.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for the procedure, typical sites of service, and what to expect in claims workflow when this code is billed. The publication also highlights benchmarking and policy considerations relevant to hospital and surgical departments, clinical documentation essentials tied to diagnosis and surgical findings, and potential areas where prior authorization or utilization management commonly arises.
Data not available in the input for detailed payer-specific reimbursement rates, associated taxonomies, ICD-10 mappings, and related code groupings. The content is intended to provide a national-level clinical and billing orientation to CPT code 49215 for clinicians, coding professionals, and policy analysts.
Billing Code Overview
CPT code 49215 describes the surgical removal of an abnormal mass located in the sacrococcygeal region near the base of the spine. The procedure is performed to treat or obtain tissue for diagnosis of benign or malignant tumors. Sacrococcygeal tumors most commonly involve newborns, though presentation can vary by age and clinical context.
-
Service type: Surgical excision of a sacrococcygeal mass
-
Typical site of service: Operating room or surgical suite, with potential inpatient or outpatient admission depending on patient age, clinical complexity, and perioperative needs
Data not available in the input for payers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is a neonate or young infant presenting with a palpable sacrococcygeal mass discovered at birth or on newborn exam, sometimes identified prenatally on ultrasound. The mass may cause constipation, urinary retention, skin irritation, infection, or be suspected of harboring malignant elements (e.g., yolk sac tumor). Initial evaluation includes physical exam, pelvic ultrasound and/or MRI to define extent and relation to pelvic structures, baseline labs including alpha‑fetoprotein when malignancy is suspected, and multidisciplinary consultation (pediatric surgery, pediatric neurosurgery, pediatric oncology as indicated). The operative workflow often includes preoperative anesthesia evaluation, positioning for posterior approach, surgical excision of the sacrococcygeal tumor with preservation of sphincter function when possible, intraoperative frozen section if indicated, and specimen sent to pathology. Postoperative care includes pain management, wound care, monitoring for neurologic or urologic deficits, and oncology follow‑up if malignancy is confirmed. Coding for the definitive excision uses 49215 for sacrococcygeal tumor resection; perioperative modifiers and relevant global period rules are applied per payer policy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the procedure requires substantially greater work than typical due to extensive dissection, large tumor size, or significant intraoperative complexity. |